Welcome to LookChem.com Sign In|Join Free

CAS

  • or

133855-98-8

Post Buying Request

133855-98-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

133855-98-8 Usage

Description

1-[[(2S,3S)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole is a complex organic compound with a unique molecular structure that features a triazole ring and a chiral oxiran moiety. 1-[[(2S,3S)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole is characterized by its stereochemistry, with the 2S,3S configuration, and the presence of a chlorophenyl and a fluorophenyl group attached to the oxiran ring. Its chemical properties and structure make it a potential candidate for various applications, particularly in the field of agriculture and pharmaceuticals.

Uses

Used in Agricultural Industry:
1-[[(2S,3S)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole is used as a fungicide for controlling fungal infections in crops. It works by inhibiting the metabolism and growth of mycelia, which are the vegetative part of fungi responsible for nutrient absorption and growth. 1-[[(2S,3S)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole helps protect plants from various fungal diseases, ensuring a healthy and productive crop yield.
Used in Pharmaceutical Industry:
1-[[(2S,3S)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole may also have potential applications in the pharmaceutical industry due to its unique chemical structure and properties. 1-[[(2S,3S)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole could be further studied and developed as a potential drug candidate for treating various diseases, such as fungal infections or other conditions that may benefit from its specific mode of action.

Flammability and Explosibility

Notclassified

Check Digit Verification of cas no

The CAS Registry Mumber 133855-98-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,8,5 and 5 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 133855-98:
(8*1)+(7*3)+(6*3)+(5*8)+(4*5)+(3*5)+(2*9)+(1*8)=148
148 % 10 = 8
So 133855-98-8 is a valid CAS Registry Number.
InChI:InChI=1/C17H13ClFN3O/c18-15-4-2-1-3-14(15)16-17(23-16,9-22-11-20-10-21-22)12-5-7-13(19)8-6-12/h1-8,10-11,16H,9H2/t16-,17-/m0/s1

133855-98-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[[(2S,3R)-3-(2-chlorophenyl)-2-(4-fluorophenyl)oxiran-2-yl]methyl]-1,2,4-triazole

1.2 Other means of identification

Product number -
Other names Epoxiconazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:133855-98-8 SDS

133855-98-8Downstream Products

133855-98-8Relevant articles and documents

Evaluating the enantioselective distribution, degradation and excretion of epoxiconazole in mice following a single oral gavage

Wang, Dezhen,Qiu, Jing,Zhu, Wentao,Zhang, Ping,Deng, Nian,Wang, Xinru,Wang, Yao,Zhou, Zhiqiang

, p. 1009 - 1015 (2015)

1. The enantiomeric enrichment or degradation of epoxiconazole has been reported in grape, soil, tubifex and mealworm beetle. But, little is known about its enantioselective behaviors in mammals.2. To further understand differences in the distribution, degradation and excretion of epoxiconazole enantiomers in vivo, male CD-1 mice were selected as the test model to investigate the enantioselective behaviors after a single oral gavage. Mice were sacrificed after 1 h, 3 h, 7 h, 12 h, 24 h, 48 h, 72 h treatment, blood, tissues and excretions were collected for epoxiconazole analysis by LC-MS/MS.3. On the Lux-Cellulose-1 chiral column, an enrichment of the second eluting (+)-epoxiconazole was generally observed, and feces and urine showed similar EF with major tissues.4. To elucidate the potential role of intestinal bacterial flora in stereospecific degradation of epoxiconazole, mice fecal flora were cultured in vitro and incubated with epoxiconazole for 48 h. Results showed that (-)-epoxiconazole was preferentially degraded by intestinal bacterial.5. These results may provide useful information for risk assessment of epoxiconazole on non-target animals.

Method for reducing 1,3,4-triazole substituent in 1,2,4-triazole alkylation reaction process

-

Paragraph 0031-0034, (2019/12/25)

The invention relates to a method for reducing a 1,3,4-triazole substituent in 1,2,4-triazole alkylation reaction process. The method comprises the steps that 1, 2, 4-triazole and an alkylation reagent are subjected to an alkylation reaction in the presence of an alkali and a catalyst, after the reaction is finished, 1, 2, 4-triazole substituent is obtained through aftertreatment, and the catalystis one or a combination of more of polyether, cyclic crown ether, quaternary ammonium salt, quaternary phosphorus salt, quaternary ammonium base and tertiary amine. The method is simple to operate; the method is wide in application range, the content of the 1, 3, 4-triazole substituent in the alkylation reaction process can be reduced, the yield of the 1, 2, 4-triazole substituent is increased, the reaction time is shortened, the reaction temperature is reduced, solvent use is reduced or avoided, the resource utilization rate is increased, three wastes are reduced, the production cost is reduced, and the method meets the requirements of a green and environment-friendly process.

Epoxiconazole intermediate, preparation method thereof, and preparation method of epoxiconazole

-

Paragraph 0071; 0072-0076; 0081, (2019/02/13)

The invention relates to an epoxiconazole intermediate, a preparation method thereof, and a preparation method of epoxiconazole. The epoxiconazole intermediate is a compound with a structural formulaIII shown in the description, and X in the formula III is Br or Cr. The preparation methods have the advantages of cheap and easily available raw materials, simple steps, high safety, few pollution ofthree wastes, mild reaction conditions, green, clean and environmentally-friendly reagents and reaction processes, suitableness for industrial production, and realization of high yield and high content of the final products.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 133855-98-8